Lasonil Pain Relief 10% Ibuprofen Gel 120 g

Pain reliever gel based on ibuprofen lysine salt.

Therapeutic indications

Lasonil Antidolore Gel is used in the local treatment of bruises, sprains, myalgia, muscle strains, stiff neck.

Dosage and Posology

The drug should be taken according to the following doses and methods: 2-4 applications per day on the painful part.

Elderly patients should adhere to the minimum dosages indicated above. Apply a thin layer of gel on the area to be treated with a light massage. Use the medicine for the shortest period possible. Wash your hands thoroughly and for a long time after application.

Overdose

There are no known cases of overdose.

Contraindications

• Hypersensitivity to product components
• Due to the possibility of cross-sensitization, the medicinal product should not be administered to patients in whom acetylsalicylic acid or other non-steroidal anti-inflammatory drugs have caused asthma, rhinitis, urticaria or other allergic manifestations.
• Pregnancy
• Feeding time
• Children and adolescents under the age of 14.

Side effects

Undesirable effects can be minimized by using the lowest effective dose for the shortest possible duration of treatment needed to control symptoms. Skin reactions with erythema, itching, irritation, sensation of heat or burning and contact dermatitis have been reported with some non-steroidal anti-inflammatory drugs derived from propionic acid for local or transdermal use. There have also been some reports of bullous eruptions of varying severity, including Stevens Johnson syndrome, and toxic epidermal necrolysis (very rarely). Photosensitivity reactions are possible.

Pregnancy and breastfeeding

The use of Lasonil Antidolore is contraindicated in pregnancy and breastfeeding. Inhibition of prostaglandin synthesis can adversely affect pregnancy and / or embryo / fetal development.

Results of epidemiological studies suggest an increased risk of miscarriage and cardiac malformation and gastroschisis after use of a prostaglandin synthesis inhibitor in early pregnancy. The absolute risk of cardiac malformations increased from less than 1% to approximately 1.5%. The risk was considered to increase with dose and duration of therapy. In animals, administration of prostaglandin synthesis inhibitors has been shown to cause increased pre- and post-implantation loss and embryo / fetal mortality. Furthermore, an increased incidence of various malformations, including cardiovascular malformations, has been reported in animals given prostaglandin synthesis inhibitors during the organ genetic period.

During the third trimester of pregnancy, all prostaglandin synthesis inhibitors can expose the fetus to: cardiopulmonary toxicity (with premature closure of the arterial duct and pulmonary hypertension); renal dysfunction, which can progress to renal failure with oligo-hydroamnios. The mother and the newborn, at the end of pregnancy, to: possible prolongation of the bleeding time, and antiplatelet effect which can occur even at very low doses; inhibition of uterine contractions resulting in delayed or prolonged labor.

Special warnings

It is advisable to avoid the application of Lasonil Anti Pain Gel in correspondence of open wounds or continuous lesions of the skin. The use, especially if prolonged, of topical drugs can give rise to sensitization and local irritation phenomena. In this case, stop the treatment and consult your doctor to establish a suitable therapy. After a short period of treatment without appreciable results, consult your doctor. To avoid any hypersensitivity or photosensitization phenomena, avoid exposure to direct sunlight, including the solarium, during the treatment and in the following two weeks.

In case of allergic reactions or major adverse reactions (skin reactions, some of them fatal, such as exfoliative dermatitis, Stevens-Johnson syndrome and toxic epidermal necrolysis) therapy must be discontinued immediately (see section 4.8). Patients appear to be at higher risk in the early stages of therapy: the onset of skin reactions occur in most cases within the first month of treatment.
Do not use Lasonil Antidolore together with another NSAID or, in any case, do not use more than one NSAID at a time.

Important information about some of the ingredients of Lasonil Pain Relief: the medicine contains methyl sodium para-oxybenzoate and ethyl sodium para-hydroxybenzoate which may cause allergic reactions (including delayed).

Expiry and retention

Check the expiration date indicated on the package. The expiry date indicated on the package refers to the product in intact packaging, correctly stored.

Warning : do not use the medicine after the expiry date indicated on the package.

Composition

100 g of Lasonil Anti Pain Gel contains:

Active principle

Ibuprofen lysine salt 10 g

Excipients

Isopropanol, hydroxyethylcellulose, methyl sodium para-oxybenzoate, ethyl para-hydroxybenzoate sodium, glycerol, lavender essence, purified water.